4gr0
From Proteopedia
(Difference between revisions)
m (Protected "4gr0" [edit=sysop:move=sysop]) |
|||
(6 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhibitor RXP470B== | |
+ | <StructureSection load='4gr0' size='340' side='right'caption='[[4gr0]], [[Resolution|resolution]] 1.50Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[4gr0]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4GR0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4GR0 FirstGlance]. <br> | ||
+ | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.497Å</td></tr> | ||
+ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=R4B:N-[(2S)-3-[(R)-(4-BROMOPHENYL)(HYDROXY)PHOSPHORYL]-2-{[3-(3-CHLOROBIPHENYL-4-YL)-1,2-OXAZOL-5-YL]METHYL}PROPANOYL]-L-ALANYL-L-ALANINAMIDE'>R4B</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4gr0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4gr0 OCA], [https://pdbe.org/4gr0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4gr0 RCSB], [https://www.ebi.ac.uk/pdbsum/4gr0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4gr0 ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/MMP12_HUMAN MMP12_HUMAN] May be involved in tissue injury and remodeling. Has significant elastolytic activity. Can accept large and small amino acids at the P1' site, but has a preference for leucine. Aromatic or hydrophobic residues are preferred at the P1 site, with small hydrophobic residues (preferably alanine) occupying P3. | ||
- | + | ==See Also== | |
- | + | *[[Matrix metalloproteinase 3D structures|Matrix metalloproteinase 3D structures]] | |
- | + | __TOC__ | |
+ | </StructureSection> | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Beau F]] | ||
+ | [[Category: Cassar-Lajeunesse E]] | ||
+ | [[Category: Devel L]] | ||
+ | [[Category: Dive V]] | ||
+ | [[Category: Stura EA]] | ||
+ | [[Category: Vera L]] |
Current revision
Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhibitor RXP470B
|
Categories: Homo sapiens | Large Structures | Beau F | Cassar-Lajeunesse E | Devel L | Dive V | Stura EA | Vera L